| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/02/2007 | US20070178527 Human platelet-derived growth factor receptors |
| 08/02/2007 | US20070178520 Screening assay for modulators of interaction between interleukin-12 and/or -23 with their receptors |
| 08/02/2007 | US20070178512 Modified carbocyanine dyes and their conjugates |
| 08/02/2007 | US20070178511 Modified carbocyanine dyes and their conjugates |
| 08/02/2007 | US20070178509 kit for the diagnosis or detection of cancer in a mammal; biomarkers for distinguishing between tumors of differing metastatic potential |
| 08/02/2007 | US20070178502 Methods for determining the prognosis for cancer patients using TUCAN |
| 08/02/2007 | US20070178492 Human tumor necrosis factor receptor polynucleotides |
| 08/02/2007 | US20070178488 Methods for detecting modulators of cytokine receptor zalpha11 |
| 08/02/2007 | US20070178483 Novel cell-based assays for G-protein-coupled receptor-mediated activities |
| 08/02/2007 | US20070178472 Methods of identifying adipocyte specific genes, the genes identified, and their uses |
| 08/02/2007 | US20070178471 Methods, kits and compositions pertaining to linear beacons |
| 08/02/2007 | US20070178467 Gm1 promoter and use thereof |
| 08/02/2007 | US20070178462 Nucleic acid molecules encoding novel murine low-voltage activated calcium channel proteins, designated-alpha1h, encoded proteins and methods of use thereof |
| 08/02/2007 | US20070178458 Methods of diagnosis and prognosis of ovarian cancer II |
| 08/02/2007 | US20070178451 Nucleic acid sequences from Chlorella sarokiniana and uses thereof |
| 08/02/2007 | US20070178439 Control of es cell self renewal and lineage specification, and medium therefor |
| 08/02/2007 | US20070178122 Fusion proteins comprising modified allergens of the ns-ltps family, use thereof and pharmaceutical compositions comprising the same |
| 08/02/2007 | US20070178117 chimeric protein comprises epitopes of the loop 5 region and/or the alpha helix 5 region of outer surface protein C (OspC) types associated with mammalian Borrelia infections; vaccine and diagnostic for Lyme disease |
| 08/02/2007 | US20070178116 Group B streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof |
| 08/02/2007 | US20070178114 Novel kallikrein gene |
| 08/02/2007 | US20070178110 Surface-located campylobacter jejuni polypeptides |
| 08/02/2007 | US20070178109 glycoprotein 120; fusion proteins; myelin basic protein; autoimmune diseases; genetic vaccines |
| 08/02/2007 | US20070178108 Colon Specific Gene and Protein and Cancer |
| 08/02/2007 | US20070178105 FHIT proteins and nucleic acids and methods based thereon |
| 08/02/2007 | US20070178096 producing an antibody by inoculating an animal with a polypeptide; monoclonal antibody specifically binds to a zalpha11 polypeptide; treating blood disorders |
| 08/02/2007 | US20070178094 Autoimmune diseases; antitumor agents; antiallergens; enhancing the immune response of an individual to a specific molecule, by enhancing the MHC class II presentation of an antigenic epitope of the molecule to T lymphocytes of the individual |
| 08/02/2007 | US20070178089 Mucosal vascular addressins and uses thereof |
| 08/02/2007 | US20070178088 Fibronectins; drug screening; treating cardiovascular/nervous system disorders |
| 08/02/2007 | US20070178086 Monoclonal antibody against ABCA1 |
| 08/02/2007 | US20070178085 BoNT/A Peptides and Methods of Predicting and Reducing Immunoresistance to Botulinum Toxin Therapy |
| 08/02/2007 | CA2650072A1 Recombinant human epo-fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo |
| 08/02/2007 | CA2639900A1 Methods for breeding glyphosate resistant plants and compositions thereof |
| 08/02/2007 | CA2638799A1 Cd86 and cd80 receptor competition assays |
| 08/02/2007 | CA2638773A1 Vasopressin pathway polymorphisms as indicators of subject outcome in critically ill subjects |
| 08/02/2007 | CA2637895A1 Use of a high molecular weight extracellular hemoglobin for the manufacture of a medicament for treating and/or preventing diseases by inhibition of calcium |
| 08/02/2007 | CA2637295A1 Fgf2-binding peptides and uses thereof |
| 08/02/2007 | CA2636867A1 Vaccines and immunotherapeutics using codon optimized il-15 and methods for using the same |
| 08/01/2007 | EP1813676A2 Retroviral vectors pseudotyped with influenza virus hemagglutin for gene delivery |
| 08/01/2007 | EP1813672A2 Transgenic non-human animals capable of producing heterologous antibodies |
| 08/01/2007 | EP1813626A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof, antigens recognized thereby and cells obtained thereby |
| 08/01/2007 | EP1813625A1 Method of modulating the profileration of medullary thyroid carcinoma cells |
| 08/01/2007 | EP1813624A1 Methods and compositions for the prevention and treatment of anemia |
| 08/01/2007 | EP1812796A1 Pkp3 oncogene as a prognostic indicator for lung cancer |
| 08/01/2007 | EP1812794A2 Autocrine growth factor receptors and methods |
| 08/01/2007 | EP1812593A2 Tubulin mutation diagnostic |
| 08/01/2007 | EP1812579A1 A non-human animal alzheimer's disease model and uses thereof |
| 08/01/2007 | EP1812578A2 Suppression of endogenous immunoglobulin expression in non-human transgenic animals |
| 08/01/2007 | EP1812574A2 Soluble bifunctional proteins |
| 08/01/2007 | EP1812573A1 Mutant porcine reproductive and respiratory syndrome virus |
| 08/01/2007 | EP1812572A1 Method for controlling insects of the order diptera using a bacillus thuringiensis strain |
| 08/01/2007 | EP1812571A1 Polypeptides having antimicrobial activity and polynucleotides encoding same |
| 08/01/2007 | EP1812476A1 Anti-il-22ra antibodies and binding partners and methods of using in inflammation |
| 08/01/2007 | EP1812474A2 Multi-domain amphipathic helical peptides and methods of their use |
| 08/01/2007 | EP1812472A1 Polypeptides that bind baff and/or april |
| 08/01/2007 | EP1812471A2 Peptides for use in treating of obesity |
| 08/01/2007 | EP1812470A1 Cyclization of a peptide |
| 08/01/2007 | EP1812469A2 T cell proteins and nucleotides encoding the same |
| 08/01/2007 | EP1812468A2 Platelet factor 4 variant 1 (pf4var1) related inhibitors of angiogenesis |
| 08/01/2007 | EP1812467A1 PEPTIDE ABLE TO BREAK THE m-p53/p63, m-p53/ p73 AND m-p53/RESPECTIVE ISOFORM PROTEINS COMPLEX FORMED IN THE TUMOR CELLS AND USES THEREOF IN THE PHARMACOLOGICAL FIELD |
| 08/01/2007 | EP1812466A2 Compositions and methods for the control of mammary cell number |
| 08/01/2007 | EP1812465A1 Novel composition and methods for the treatment of immune related diseases |
| 08/01/2007 | EP1812464A2 Insectidical polypeptides and methods of use thereof |
| 08/01/2007 | EP1812463A2 Group 2 mite polypeptide variants |
| 08/01/2007 | EP1812462A2 Vwfa and/or ant_ig domain containing proteins |
| 08/01/2007 | EP1812459A1 Method for the mass production of multimeric mannose binding lectin |
| 08/01/2007 | EP1812076A2 Platelet-derived growth factor compositions and methods of use thereof |
| 08/01/2007 | EP1812058A2 Chlamydia trachomatis antigens for vaccine and diagnostic use |
| 08/01/2007 | EP1812055A1 Chlamydia antigens and uses thereof |
| 08/01/2007 | EP1812046A2 Melanocortin receptor binding mimetibodies, compositions, methods and uses |
| 08/01/2007 | EP1812032A2 Tissue factor composition and methods |
| 08/01/2007 | EP1812030A2 Anti-angiogenic peptides and methods of use thereof |
| 08/01/2007 | EP1812026A2 Recombinant newcastle disease virus |
| 08/01/2007 | EP1745078A4 Method for the purification of albumin conjugates |
| 08/01/2007 | EP1687402A4 Chimeric metabotropic glutamate receptors and uses thereof |
| 08/01/2007 | EP1636261B1 Thrombopoietin proteins with improved properties |
| 08/01/2007 | EP1622927A4 Love variant regulator molecules |
| 08/01/2007 | EP1581622A4 Erythropoietin: remodeling and glycoconjugation of erythropoietin |
| 08/01/2007 | EP1573324A4 Cytochrome c acetylation |
| 08/01/2007 | EP1565754B1 New uses of proteins encoded by ble genes and antibiotics from the bleomycin family |
| 08/01/2007 | EP1539221A4 Transferrin fusion protein libraries |
| 08/01/2007 | EP1516184B1 Cell-selective delivery system |
| 08/01/2007 | EP1487866B1 Novel polypeptide scaffolds and use thereof |
| 08/01/2007 | EP1470226B1 Control of gene expression using a complex of an oligonucleotide and a regulatory peptide |
| 08/01/2007 | EP1434857B1 Method for production of recombinant proteins in eukaryote cells |
| 08/01/2007 | EP1432819B1 Method for determining cell cycle position |
| 08/01/2007 | EP1381681B1 The nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use |
| 08/01/2007 | EP1332158B1 Peptides, the production and use thereof for binding immunoglobulins |
| 08/01/2007 | EP1287134B1 The human voltage-gated sodium channel beta-1a subunit and methods of use |
| 08/01/2007 | EP1214339B1 Polypeptides from moraxella (branhamella) catarrhalis |
| 08/01/2007 | EP1185615B1 Recombinant influenza viruses for vaccines and gene therapy |
| 08/01/2007 | EP1141293B1 Vascular endothelial growth factor-x |
| 08/01/2007 | EP1007537B1 Receptor protein designated 2f1 |
| 08/01/2007 | EP0884947B1 Dna vaccination for induction of suppressive t cell response |
| 08/01/2007 | EP0695347B1 Methods and materials for treatment of individuals infected with intracellular infectious agents |
| 08/01/2007 | CN1329513C Avian polynucleotide vaccine formula for anti pig's diseases |
| 08/01/2007 | CN1329512C Modulator of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptors |
| 08/01/2007 | CN1329508C Process method for producing HMG-CoA reductase inhibitor |
| 08/01/2007 | CN1329412C Binding protein of tall fescue drought reacting element, its coding gene and use thereof |
| 08/01/2007 | CN1329411C Process for producing soy protein |
| 08/01/2007 | CN1329410C Acyl transfer with stabilized transition complex using catalyst with catalytic imidazole (e. g. histidine) function |